At Lonza's facility in Bend (OR), our core capabilities include bioavailability enhancement, respiratory delivery, and multiparticulates. Our comprehensive offering extends beyond these core capabilities, encompassing material-sparing formulation development that continues seamlessly through the commercialization phase. Our early-phase clinical manufacturing facility provides agile, quick-to-clinic capabilities. The co-location of our expert formulators with our commercial manufacturing facility will ensure the success of your molecule.
The presentation will:
- Explore strategies how to overcome your bioavailability enhancement challenges
- Discuss the respiratory delivery expertise of the Bend Inhalation Group
- Demonstrate how our experts can help you to formulate multiparticulates that align with your project goals